COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,731 Articles (22,502 medRxiv, 8,229 bioRxiv)

Most recent first Previous |  Page 245: Articles 2441-2450  | Next

Antiviral humoral immunity against SARS-CoV-2 Omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals
Kosugi, Y., Kaku, Y., Hinay, A. A., Guo, Z., Uriu, K., Kihara, M., Saito, F., Uwamino, Y., Kuramochi, J., Shirakawa, K., Takaori-Kondo, A., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Sato, K.
10.1101/2023.11.29.569330 — Posted: 2023-11-30
Persistent immune imprinting after XBB.1.5 COVID vaccination in humans
Tortorici, M. A., Addetia, A., Seo, A. J., Brown, J., Sprouse, K., Logue, J., Clarke, E., Franko, N., Chu, H., Veesler, D.
10.1101/2023.11.28.569129 — Posted: 2023-11-30
Mechanistic insights into ligand dissociation from the SARS-CoV-2 spike glycoprotein
Hasse, T. A., Mantei, E., Shahoei, R., Pawnikar, S., Wang, J., Miao, Y., Huang, Y.-m. M.
10.1101/2023.11.29.569184 — Posted: 2023-11-30
COVID-19 infection wave mortality from surveillance data in the Philippines using machine learning
Migrino, J. R., Batangan, A. R. U., Abello, R. M. R.
10.1101/2023.11.28.23299037 — Posted: 2023-11-30
Diagnostic Performance of Rapid Antigen Testing for SARS-CoV-2: The COVid-19 AntiGen (COVAG) Extension study
Wertenauer, C., Dressel, A., Wieland, E., Wertenauer, H.-J., Braitmaier, H., Straub, A., Luetzner, N., Maerz, W.
10.1101/2023.11.29.23299183 — Posted: 2023-11-29
Examining the association of live virus neutralisation activity of capillary microsamples and risk of SARS-CoV-2 infections: a nested case control study within the Virus Watch community cohort
Yavlinsky, A., Nguyen, V., Beale, S., Wall, E., Wu, M. Y., Braithwaite, I., Kovar, J., Shrotri, M., Navaratnam, A. M. D., Fong, W. L. E., Byrne, T. E., Balloux, F., Abubakar, I., Cowling, B. J., Hayward, A., Aldridge, R. W.
10.1101/2023.11.28.23299156 — Posted: 2023-11-29
Human Cytokine and Coronavirus Nucleocapsid Protein Interactivity Using Large-Scale Virtual Screens
Tomezsko, P. J., Ford, C. T., Meyer, A. E., Michaleas, A. M., Jaimes, R.
10.1101/2023.11.28.569056 — Posted: 2023-11-29
SARS-CoV-2 Orphan Gene ORF10 Contributes to More Severe COVID-19 Disease
Haltom, J. A., Trovao, N. S., Guarnieri, J., Vincent, P., Singh, U., Tsoy, S., O'Leary, C. A., Bram, Y., Widjaja, G. A., Cen, Z., Meller, R., Baylin, S. B., Moss, W. N., Nikolau, B. J., Enguita, F. J., Wallace, D. C., Beheshti, A., Schwartz, R., Wurtele, E. S.
10.1101/2023.11.27.23298847 — Posted: 2023-11-29
Tracking the impact of government response to COVID-19 epidemic: Evidence from India
Mishra, K.
10.1101/2023.11.27.23299097 — Posted: 2023-11-29
Unveiling Vulnerabilities in Maternal-Child Health amidst COVID-19: A Cross-Sectional Study on Food Insecurity and Socio-Demographic Disparities in the U.S.
Henkes, Z., Romo-Palafox, M.
10.1101/2023.11.28.23299080 — Posted: 2023-11-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).